Cargando…
Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice
PURPOSE: Evaluating patients and treatment decisions in a multidisciplinary tumor board has led to better quality of care and longer survival in cancer patients. The aim of this study was to evaluate tumor board recommendations for thoracic oncology patients regarding guideline adherence and transfe...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465379/ https://www.ncbi.nlm.nih.gov/pubmed/37402967 http://dx.doi.org/10.1007/s00432-023-05025-1 |
_version_ | 1785098660802985984 |
---|---|
author | Walter, Julia Moeller, Caroline Resuli, Blerina Kauffmann-Guerrero, Diego Manapov, Farkhad Dinkel, Julien Neumann, Jens Kovacs, Julia Schneider, Christian Huber, Rudolf M. Tufman, Amanda |
author_facet | Walter, Julia Moeller, Caroline Resuli, Blerina Kauffmann-Guerrero, Diego Manapov, Farkhad Dinkel, Julien Neumann, Jens Kovacs, Julia Schneider, Christian Huber, Rudolf M. Tufman, Amanda |
author_sort | Walter, Julia |
collection | PubMed |
description | PURPOSE: Evaluating patients and treatment decisions in a multidisciplinary tumor board has led to better quality of care and longer survival in cancer patients. The aim of this study was to evaluate tumor board recommendations for thoracic oncology patients regarding guideline adherence and transferal of recommendations into clinical practice. METHODS: We evaluated tumor board recommendations of the thoracic oncology tumor board at Ludwig-Maximilians University (LMU) Hospital Munich between 2014 and 2016. We compared patient characteristics between guideline-adherent and non-guideline-adherent recommendations, as well as between transferred and non-transferred recommendations. We used multivariate logistic regression models to evaluate factors associated with guideline adherence. RESULTS: Over 90% of recommendations by the tumor board were either adherent to the guidelines (75.5%) or over fulfilling guidelines (15.6%). Almost 90% of recommendations were transferred to clinical practice. If a recommendation was not according to the guidelines, the reason was mostly associated with the general condition (age, Charlson comorbidity index, ECOG) of the patient or due to the patients’ request. Surprisingly, sex also had a significant influence on the guideline adherence of recommendations, with females being more likely to get recommendations not according to the guidelines. CONCLUSION: In conclusion, the results of this study are promising, as the guideline adherence of recommendations as well as the transferal of recommendations into clinical practice were high. In the future, a special focus should be put on fragile patients as well as female patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-05025-1. |
format | Online Article Text |
id | pubmed-10465379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-104653792023-08-31 Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice Walter, Julia Moeller, Caroline Resuli, Blerina Kauffmann-Guerrero, Diego Manapov, Farkhad Dinkel, Julien Neumann, Jens Kovacs, Julia Schneider, Christian Huber, Rudolf M. Tufman, Amanda J Cancer Res Clin Oncol Research PURPOSE: Evaluating patients and treatment decisions in a multidisciplinary tumor board has led to better quality of care and longer survival in cancer patients. The aim of this study was to evaluate tumor board recommendations for thoracic oncology patients regarding guideline adherence and transferal of recommendations into clinical practice. METHODS: We evaluated tumor board recommendations of the thoracic oncology tumor board at Ludwig-Maximilians University (LMU) Hospital Munich between 2014 and 2016. We compared patient characteristics between guideline-adherent and non-guideline-adherent recommendations, as well as between transferred and non-transferred recommendations. We used multivariate logistic regression models to evaluate factors associated with guideline adherence. RESULTS: Over 90% of recommendations by the tumor board were either adherent to the guidelines (75.5%) or over fulfilling guidelines (15.6%). Almost 90% of recommendations were transferred to clinical practice. If a recommendation was not according to the guidelines, the reason was mostly associated with the general condition (age, Charlson comorbidity index, ECOG) of the patient or due to the patients’ request. Surprisingly, sex also had a significant influence on the guideline adherence of recommendations, with females being more likely to get recommendations not according to the guidelines. CONCLUSION: In conclusion, the results of this study are promising, as the guideline adherence of recommendations as well as the transferal of recommendations into clinical practice were high. In the future, a special focus should be put on fragile patients as well as female patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-05025-1. Springer Berlin Heidelberg 2023-07-05 2023 /pmc/articles/PMC10465379/ /pubmed/37402967 http://dx.doi.org/10.1007/s00432-023-05025-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Walter, Julia Moeller, Caroline Resuli, Blerina Kauffmann-Guerrero, Diego Manapov, Farkhad Dinkel, Julien Neumann, Jens Kovacs, Julia Schneider, Christian Huber, Rudolf M. Tufman, Amanda Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice |
title | Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice |
title_full | Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice |
title_fullStr | Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice |
title_full_unstemmed | Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice |
title_short | Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice |
title_sort | guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465379/ https://www.ncbi.nlm.nih.gov/pubmed/37402967 http://dx.doi.org/10.1007/s00432-023-05025-1 |
work_keys_str_mv | AT walterjulia guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT moellercaroline guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT resuliblerina guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT kauffmannguerrerodiego guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT manapovfarkhad guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT dinkeljulien guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT neumannjens guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT kovacsjulia guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT schneiderchristian guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT huberrudolfm guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice AT tufmanamanda guidelineadherenceoftumorboardrecommendationsinlungcancerandtransferintoclinicalpractice |